Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7817 |
Intermediate Similarity |
NPD1058 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6691 |
Remote Similarity |
NPD8836 |
Approved |
0.6667 |
Remote Similarity |
NPD248 |
Discontinued |
0.6646 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.651 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.6506 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6491 |
Remote Similarity |
NPD2647 |
Phase 3 |
0.649 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.6478 |
Remote Similarity |
NPD4240 |
Approved |
0.6474 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6442 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6433 |
Remote Similarity |
NPD1313 |
Approved |
0.642 |
Remote Similarity |
NPD4183 |
Phase 3 |
0.642 |
Remote Similarity |
NPD4182 |
Phase 3 |
0.6354 |
Remote Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.6354 |
Remote Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.6354 |
Remote Similarity |
NPD5682 |
Phase 3 |
0.6325 |
Remote Similarity |
NPD3107 |
Discontinued |
0.631 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.6289 |
Remote Similarity |
NPD3695 |
Approved |
0.6289 |
Remote Similarity |
NPD193 |
Suspended |
0.6289 |
Remote Similarity |
NPD3696 |
Approved |
0.6243 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.6215 |
Remote Similarity |
NPD5666 |
Phase 2 |
0.6213 |
Remote Similarity |
NPD2624 |
Phase 2 |
0.6211 |
Remote Similarity |
NPD185 |
Approved |
0.619 |
Remote Similarity |
NPD8831 |
Approved |
0.619 |
Remote Similarity |
NPD8833 |
Approved |
0.6154 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.6154 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.6149 |
Remote Similarity |
NPD7988 |
Suspended |
0.614 |
Remote Similarity |
NPD5321 |
Phase 3 |
0.6135 |
Remote Similarity |
NPD249 |
Approved |
0.6135 |
Remote Similarity |
NPD250 |
Approved |
0.6135 |
Remote Similarity |
NPD166 |
Approved |
0.6131 |
Remote Similarity |
NPD1369 |
Phase 2 |
0.6131 |
Remote Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.6127 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.6127 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.6111 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.6087 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.6084 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.6077 |
Remote Similarity |
NPD5962 |
Phase 2 |
0.6069 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6061 |
Remote Similarity |
NPD195 |
Approved |
0.6061 |
Remote Similarity |
NPD186 |
Discovery |
0.6045 |
Remote Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.6023 |
Remote Similarity |
NPD1732 |
Phase 3 |
0.6022 |
Remote Similarity |
NPD3341 |
Clinical (unspecified phase) |
0.6011 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.5988 |
Remote Similarity |
NPD2927 |
Phase 3 |
0.5979 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.5977 |
Remote Similarity |
NPD6074 |
Clinical (unspecified phase) |
0.5975 |
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.5975 |
Remote Similarity |
NPD4763 |
Clinical (unspecified phase) |
0.5959 |
Remote Similarity |
NPD6816 |
Phase 3 |
0.5957 |
Remote Similarity |
NPD3419 |
Clinical (unspecified phase) |
0.5957 |
Remote Similarity |
NPD6761 |
Discontinued |
0.5956 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.5956 |
Remote Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.5956 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.5949 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.5944 |
Remote Similarity |
NPD3799 |
Suspended |
0.5917 |
Remote Similarity |
NPD283 |
Approved |
0.5916 |
Remote Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.5912 |
Remote Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.5909 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.5906 |
Remote Similarity |
NPD339 |
Approved |
0.5897 |
Remote Similarity |
NPD6129 |
Phase 2 |
0.5872 |
Remote Similarity |
NPD169 |
Phase 2 |
0.5868 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.586 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.5848 |
Remote Similarity |
NPD242 |
Approved |
0.5848 |
Remote Similarity |
NPD338 |
Approved |
0.5843 |
Remote Similarity |
NPD171 |
Discontinued |
0.5842 |
Remote Similarity |
NPD7722 |
Suspended |
0.5838 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.5829 |
Remote Similarity |
NPD2793 |
Discontinued |
0.5829 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.5818 |
Remote Similarity |
NPD2179 |
Discontinued |
0.5817 |
Remote Similarity |
NPD6850 |
Phase 2 |
0.5817 |
Remote Similarity |
NPD6849 |
Phase 2 |
0.5808 |
Remote Similarity |
NPD1730 |
Discontinued |
0.5806 |
Remote Similarity |
NPD1390 |
Phase 1 |
0.5806 |
Remote Similarity |
NPD1389 |
Clinical (unspecified phase) |
0.5806 |
Remote Similarity |
NPD1388 |
Phase 1 |
0.5803 |
Remote Similarity |
NPD5462 |
Discontinued |
0.5798 |
Remote Similarity |
NPD6418 |
Phase 1 |
0.5795 |
Remote Similarity |
NPD3083 |
Approved |
0.5789 |
Remote Similarity |
NPD580 |
Discontinued |
0.5787 |
Remote Similarity |
NPD1777 |
Approved |
0.5787 |
Remote Similarity |
NPD1776 |
Approved |
0.5783 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.5771 |
Remote Similarity |
NPD5300 |
Clinical (unspecified phase) |
0.5771 |
Remote Similarity |
NPD6192 |
Phase 3 |
0.5761 |
Remote Similarity |
NPD40 |
Phase 2 |
0.5761 |
Remote Similarity |
NPD5730 |
Phase 2 |
0.5754 |
Remote Similarity |
NPD1215 |
Discontinued |
0.5754 |
Remote Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.5746 |
Remote Similarity |
NPD6828 |
Phase 2 |
0.5746 |
Remote Similarity |
NPD6827 |
Clinical (unspecified phase) |
0.5745 |
Remote Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.5745 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.5737 |
Remote Similarity |
NPD5145 |
Clinical (unspecified phase) |
0.5733 |
Remote Similarity |
NPD757 |
Phase 3 |
0.5732 |
Remote Similarity |
NPD1775 |
Approved |
0.5732 |
Remote Similarity |
NPD1085 |
Approved |
0.5723 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.5723 |
Remote Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.5722 |
Remote Similarity |
NPD2333 |
Discontinued |
0.5714 |
Remote Similarity |
NPD2221 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD4352 |
Phase 1 |
0.5714 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.5707 |
Remote Similarity |
NPD3041 |
Approved |
0.5707 |
Remote Similarity |
NPD7111 |
Discontinued |
0.5706 |
Remote Similarity |
NPD4709 |
Approved |
0.5706 |
Remote Similarity |
NPD6112 |
Approved |
0.57 |
Remote Similarity |
NPD7445 |
Phase 1 |
0.5699 |
Remote Similarity |
NPD5806 |
Clinical (unspecified phase) |
0.5698 |
Remote Similarity |
NPD8121 |
Phase 3 |
0.5698 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.5698 |
Remote Similarity |
NPD8120 |
Approved |
0.5692 |
Remote Similarity |
NPD6468 |
Clinical (unspecified phase) |
0.5692 |
Remote Similarity |
NPD6469 |
Phase 3 |
0.5689 |
Remote Similarity |
NPD9704 |
Approved |
0.5685 |
Remote Similarity |
NPD6151 |
Phase 2 |
0.5677 |
Remote Similarity |
NPD3431 |
Approved |
0.5677 |
Remote Similarity |
NPD3430 |
Approved |
0.5677 |
Remote Similarity |
NPD4262 |
Discontinued |
0.5677 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.5677 |
Remote Similarity |
NPD6619 |
Phase 3 |
0.5672 |
Remote Similarity |
NPD6521 |
Phase 3 |
0.5672 |
Remote Similarity |
NPD6520 |
Phase 3 |
0.5672 |
Remote Similarity |
NPD4612 |
Discontinued |
0.5667 |
Remote Similarity |
NPD6794 |
Approved |
0.5665 |
Remote Similarity |
NPD213 |
Clinical (unspecified phase) |
0.5665 |
Remote Similarity |
NPD214 |
Approved |
0.5663 |
Remote Similarity |
NPD2253 |
Discontinued |
0.5661 |
Remote Similarity |
NPD4902 |
Discontinued |
0.5657 |
Remote Similarity |
NPD5969 |
Clinical (unspecified phase) |
0.5652 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.565 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.5645 |
Remote Similarity |
NPD5508 |
Phase 1 |
0.5638 |
Remote Similarity |
NPD5463 |
Clinical (unspecified phase) |
0.5628 |
Remote Similarity |
NPD3081 |
Clinical (unspecified phase) |
0.5621 |
Remote Similarity |
NPD578 |
Discontinued |
0.5615 |
Remote Similarity |
NPD1637 |
Clinical (unspecified phase) |
0.5613 |
Remote Similarity |
NPD6352 |
Phase 2 |
0.5611 |
Remote Similarity |
NPD2135 |
Approved |
0.5611 |
Remote Similarity |
NPD2134 |
Approved |
0.5611 |
Remote Similarity |
NPD2136 |
Approved |
0.561 |
Remote Similarity |
NPD2602 |
Clinical (unspecified phase) |
0.5605
|
Remote Similarity |
NPD579 |
Clinical (unspecified phase) |